Assignee
EXAGEN DIAGNOSTICS INC
US·8 granted patents·12 pending applications·29 citations·filing 2002–2013
Top patents by PatentIndex Score
20 records- 0186US7923544B2Biomarkers for inflammatory bowel disease and irritable bowel syndromeEXAGEN DIAGNOSTICS INC·Filed 2010·Granted Apr 12, 2011·4 cites·15 claims
- 0284US7833720B2Biomarkers for inflammatory bowel disease and irritable bowel syndromeEXAGEN DIAGNOSTICS INC·Filed 2009·Granted Nov 16, 2010·3 cites·8 claims
- 0384US7698071B2Methods and devices relating to estimating classifier performanceEXAGEN DIAGNOSTICS INC·Filed 2009·Granted Apr 13, 2010·12 cites·16 claims
- 0479US7879553B2Biomarkers for inflammatory bowel disease and irritable bowel syndromeEXAGEN DIAGNOSTICS INC·Filed 2009·Granted Feb 1, 2011·1 cites·8 claims
- 0579US7833721B2Biomarkers for inflammatory bowel disease and irritable bowel syndromeEXAGEN DIAGNOSTICS INC·Filed 2009·Granted Nov 16, 2010·1 cites·8 claims
- 0675US7557198B2Acute myelogenous leukemia biomarkersEXAGEN DIAGNOSTICS INC·Filed 2006·Granted Jul 7, 2009·5 cites·10 claims
- 0765US2009253139A1Compositions and methods for glioma classificationEXAGEN DIAGNOSTICS INC·Filed 2009·Application pending·0 cites
- 0863US7534875B2Compositions for glioma classificationEXAGEN DIAGNOSTICS INC·Filed 2004·Granted May 19, 2009·0 cites·14 claims
- 0957US2013079245A1Biomarkers for Ulcerative Colitis and Crohn's DiseaseEXAGEN DIAGNOSTICS INC·Filed 2012·Application pending·0 cites
- 1055US2009258370A1Acute Myelogenous Leukemia BiomarkersEXAGEN DIAGNOSTICS INC·Filed 2009·Application pending·0 cites
- 1153US7561971B2Methods and devices relating to estimating classifier performanceEXAGEN DIAGNOSTICS INC·Filed 2002·Granted Jul 14, 2009·3 cites·16 claims
- 1253US2011262948A1Methods of Quantifying Methotrexate MetabolitesEXAGEN DIAGNOSTICS INC·Filed 2011·Application pending·0 cites
- 1353US2005260659A1Compositions and methods for breast cancer prognosisEXAGEN DIAGNOSTICS INC·Filed 2005·Application pending·0 cites
- 1449US2010159469A1Compositions and Methods for Breast Cancer PrognosisEXAGEN DIAGNOSTICS INC·Filed 2010·Application pending·0 cites
- 1546US2006223075A1Unique sequence hybridization probes (USP)EXAGEN DIAGNOSTICS INC·Filed 2005·Application pending·0 cites
- 1645US2013216530A1Methods for optimizing biological response modifier therapy using therapeutic drug monitoring of immunosuppressantsEXAGEN DIAGNOSTICS INC·Filed 2013·Application pending·0 cites
- 1745US2013040835A1Genes predictive of anti-TNF response in inflammatory diseasesEXAGEN DIAGNOSTICS INC·Filed 2012·Application pending·0 cites
- 1845US2005244872A1Breast cancer gene expression biomarkersEXAGEN DIAGNOSTICS INC·Filed 2005·Application pending·0 cites
- 1945US2005287578A1Methods for RNA fluorescence in situ hybridizationEXAGEN DIAGNOSTICS INC·Filed 2005·Application pending·0 cites
- 2036US2011177531A1Cell-Based Complement Activation Product Algorithm for Diagnosing Systemic Lupus ErythematosusEXAGEN DIAGNOSTICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EXAGEN DIAGNOSTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →